Dutasteride placebo

DRUG2 trials

Sponsors

GlaxoSmithKline, Dongkook Pharmaceutical Co., Ltd.

Conditions

Androgenetic AlopeciaBenign Prostatic Hyperplasia

Phase 3

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

CompletedNCT01231607

GlaxoSmithKlineAndrogenetic Alopecia

Start: 2010-10-28End: 2012-02-28Updated: 2018-08-10

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

CompletedNCT04947631

Dongkook Pharmaceutical Co., Ltd.Benign Prostatic Hyperplasia

Start: 2021-07-27End: 2023-06-12Updated: 2023-09-21